Loading clinical trials...
Loading clinical trials...
In France today, it is estimated that one in 850 people aged between 20 and 45 has been cured of cancer in childhood. Some descriptive studies have established that cancer diagnosis and treatment can affect psychological health, with an increased risk of depression, post-traumatic stress, anxiety and suicidal risk. A French study published by our team in 2015 and 2020 also showed that, as adults, 40% of former pediatric cancer patients experienced symptoms of anxiety, a rate significantly higher than that of the general French population (25%). While it is well established that it is essential to detect the onset of anxiety-depressive disorders and, if necessary, to set up conventional psychological treatment (CPT), few studies have sought to show the benefit of complementing this conventional CPT with mind-body therapies (MBT) in the post-cancer pediatric setting. This project aims to determine the benefit of mind-body therapies (hypnosis and relaxation) as a complement to conventional psychological treatment (CPT) in the management of anxiety in children, adolescents and young adults in remission from pediatric cancer or leukemia.
Age
7 - 25 years
Sex
ALL
Healthy Volunteers
No
Centre Hospitalier Universitaire
Angers, France
Centre Hospitalier Universitaire Caen Normandie
Caen, France
Centre Hospitalier Universitaire Grenoble Alpes
Grenoble, France
Institut d'Hématologie et d'Oncologie Pédiatrique
Lyon, France
Centre Hospitalier Universitaire
Rouen, France
CENTRE HOSPITALIER UNIVERSITAIRE - site NORD
Saint-Etienne, France
CENTRE HOSPITALIER UNIVERSITAIRE - site HAUTEPIERRE
Strasbourg, France
Start Date
March 2, 2026
Primary Completion Date
January 1, 2028
Completion Date
July 1, 2028
Last Updated
February 2, 2026
558
ESTIMATED participants
10 mind-body therapy sessions (hypnosis or relaxation, depending on the patient's choice)
BEHAVIORAL
9 sessions of standard psychological care
BEHAVIORAL
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
NCT07478393
NCT07456631
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions